TSX:CURAPharmaceuticals
Can Curaleaf Holdings’ (TSX:CURA) International Push Offset Slowing Domestic Growth?
Curaleaf Holdings recently reported its second quarter 2025 results, with revenue of US$314.52 million and a net loss of US$53.16 million, both reflecting a decrease compared to the same period last year.
The company’s international segment showed a very large year-over-year growth rate, highlighted by securing a new operating license in Turkey.
We'll examine how Curaleaf's sharp international segment expansion impacts its investment narrative and future growth outlook.
Rare earth metals are...